Julier Medical Raises €3 Million In Seed Financing From Sofinnova Partners To Treat Patients With Acute Ischemic Stroke

PARIS, FRANCE / January 23, 2023 / Julier Medical ("Julier"), a Paris-based medical device company developing an innovative solution for the removal of blood clots and post-stroke revascularization, today announced a successful €3 million seed financing from Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London and Milan. The funds will support the development of Julier's mechanical thrombectomy device to treat patients with Acute Ischemic Stroke (AIS) until its first clinical study. This is the fifth investment by Sofinnova's medtech acceleration fund, Sofinnova MD Start III.